₹ 366.40
16.80 (4.81%)
BSE
T
Titan Biotech
₹ 366.40
BSE
TITANBIO Financials Summary (Consolidated)
Titan Biotech revenue increased 28.20% quarter-on-quarter to ₹78 Cr in Sep 2026, while net profit increased 14.68% quarter-on-quarter to ₹13 Cr. Compared to the same quarter last year, revenue is up 40.39% and net profit is up 60.26%. EPS for the quarter stood at ₹3.04, increased from ₹2.63 in the previous quarter and down from ₹9.40 a year ago.
Titan Biotech Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of TITANBIO Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
TITANBIO Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






